Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 2/20 | 0.67 |
| ▸ | HTR1A | P08908 | 1/20 | 0.67 |
| ▸ | HTR1B | P28222 | 1/20 | 0.67 |
| ▸ | DRD2 | P14416 | 1/20 | 0.53 |
| ▸ | DRD3 | P35462 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9759115 | 0.88 | HTR1D (0.70) | HTR1DHTR1AHTR1BDRD2DRD3 | |
| SCHEMBL9759329 | 0.88 | HTR1D (0.70) | HTR1DHTR1AHTR1BDRD2DRD3 | |
| SCHEMBL9759083 | 0.87 | HTR1D (0.69) | HTR1DHTR1AHTR1BDRD2DRD3 | |
| SCHEMBL9759201 | 0.86 | HTR1D (0.67) | HTR1DHTR1AHTR1BDRD2DRD3 | |
| SCHEMBL9758848 | 0.86 | HTR1A (0.70) | HTR1DHTR1AHTR1BDRD2DRD3 | |
| SCHEMBL9759423 | 0.84 | HTR1A (0.55) | HTR1DHTR1AHTR1BDRD2DRD3 | |
| SCHEMBL9759040 | 0.82 | HTR1A (0.57) | HTR1DHTR1AHTR1BDRD2DRD3 | |
| SCHEMBL9758948 | 0.82 | HTR1D (0.72) | HTR1DHTR1AHTR1BDRD2DRD3 | |
| SCHEMBL10643830 | 0.81 | HTR1A (0.82) | HTR1DHTR1AHTR1BDRD2DRD3 | |
| Hydrochloric Acid SCHEMBL9760000 | 0.81 | HTR1A (0.56) | HTR1DHTR1AHTR1BDRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5047422-A | Treating A Disorder Of The Central Nervous System, Cardiovascular System Or Intestinal Tract | BAYER AKTIENGESELLSCHAFT (DE) | 1991-09-10 | — | — | US | disclosed |
| US-4968679-A | DISORDERS OF CENTRAL NERVOUS SYSTEM, CARDIOVASCULAR SYSTEM OR INTESTINAL TRACT | BAYER AKTIENGESELLSCHAFT (DE) | 1990-11-06 | — | — | US | disclosed |
| US-4873262-A | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS, CARDIIOVASCULAR SYSTEM OR INTESTINAL TRACT | BAYER AKTIENGESELLSCHAFT (DE) | 1989-10-10 | — | — | US | disclosed |
| EP-0272534-A2 | 8-substituted 2-aminotetralins | BAYER AG (DE) | 1988-06-29 | — | — | EP | disclosed |